EP2535072 - Subcutaneous infusion devices [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 14.04.2017 Database last updated on 02.09.2024 | |
Former | Examination is in progress Status updated on 09.01.2017 | Most recent event Tooltip | 14.04.2017 | Application deemed to be withdrawn | published on 17.05.2017 [2017/20] | Applicant(s) | For all designated states C. R. BARD, INC. 730 Central Avenue Murray Hill, NJ 07974 / US | [2012/51] | Inventor(s) | 01 /
Barron, William R. 12124 So. 4250 West Riverton, UT 84065 / US | 02 /
Burnside, Eddie K. 3107 Crestview Circle Bountiful, UT 84010 / US | 03 /
Hamatake, Bret 434 Triple Crown Way Grantsville, UT 84029 / US | 04 /
Powers, Kelly B. 8 N. Foxhill Road North Salt Lake, UT 84054 / US | [2012/51] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
Former [2012/51] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | Application number, filing date | 12180240.9 | 07.06.2005 | [2012/51] | Priority number, date | US20040577658P | 07.06.2004 Original published format: US 577658 P | [2012/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2535072 | Date: | 19.12.2012 | Language: | EN | [2012/51] | Type: | A3 Search report | No.: | EP2535072 | Date: | 27.03.2013 | Language: | EN | [2013/13] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 25.02.2013 | Classification | IPC: | A61M5/178 | [2012/51] | CPC: |
A61M5/158 (EP,US);
A61M25/005 (EP,US);
A61M25/007 (EP,US);
A61M25/0637 (EP,US);
A61M2005/1581 (EP,US);
A61M25/0662 (EP,US)
| Designated contracting states | DE, ES, FR, GB, IT [2012/51] | Title | German: | Subkutane Infusionsvorrichtungen | [2012/51] | English: | Subcutaneous infusion devices | [2012/51] | French: | Dispositifs de perfusion sous-cutanée | [2012/51] | Examination procedure | 13.08.2012 | Examination requested [2012/51] | 07.03.2013 | Amendment by applicant (claims and/or description) | 02.05.2013 | Despatch of a communication from the examining division (Time limit: M06) | 23.10.2013 | Reply to a communication from the examining division | 27.07.2016 | Despatch of a communication from the examining division (Time limit: M04) | 07.12.2016 | Application deemed to be withdrawn, date of legal effect [2017/20] | 10.01.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/20] | Parent application(s) Tooltip | EP05757206.7 / EP1768724 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050757206) is 09.08.2010 | Fees paid | Renewal fee | 13.08.2012 | Renewal fee patent year 03 | 13.08.2012 | Renewal fee patent year 04 | 13.08.2012 | Renewal fee patent year 05 | 13.08.2012 | Renewal fee patent year 06 | 13.08.2012 | Renewal fee patent year 07 | 13.08.2012 | Renewal fee patent year 08 | 27.08.2013 | Renewal fee patent year 09 | 12.06.2014 | Renewal fee patent year 10 | 10.06.2015 | Renewal fee patent year 11 | Penalty fee | Additional fee for renewal fee | 30.06.2013 | 09   M06   Fee paid on   27.08.2013 | 30.06.2016 | 12   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO8906553 (BAXTER INT [US]) [X] 1,3 * figure 5A * [Y] 2,4; | [Y]US2002123724 (DOUGLAS JOEL S [US], et al) [Y] 5-8,13,14 * paragraphs [0041] - [0045] *; | [XY]EP0810003 (TARGET THERAPEUTICS INC [US]) [X] 15 * column 7, line 41 - column 10, line 43 * * column 12, line 6 - column 16, line 21 * [Y] 2,5-8,13,14; | [Y]US4834706 (BECK ANDREW J [US], et al) [Y] 4 * column 2, line 19 - column 6, line 9 * |